CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medigen Biotechnology Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medigen Biotechnology Corp
14F, Bldg F, No. 3
Yuancyu St.
Phone: +886 226535200p:+886 226535200 TAIPEI, 115  Taiwan Ticker: 31763176
Business Summary
MEDIGEN BIOTECHNOLOGY CORP. is a Taiwan-based company principally engaged in the wholesales and distribution of general drugs. The Company is engaged in the licensing of technologies, the provision of technical services and testing services of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents, HLA typing and testing services, HLA SBT high-resolution typing reagents, HLA ABCDRDQ typing kits, nucleic acid testing reagents for the genotyping of human platelet, nucleic acid extraction instruments and reagents and blood screening specialized automated nucleic acid detection platforms. It also provides medical beauty care products. The Company distributes its products in Taiwan market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager Shi-ChungChang 7/1/2023 9/1/2000
Senior Finance Manager-Administrative and Accounting Department, Corporate Governance Officer Feng-HuaChen 8/9/2022 1/1/2021
Chief Scientific Officer-Cell Therapy Department Chieh-LiangLin 6/4/2019 6/4/2019
7 additional Officers and Directors records available in full report.

Business Names
Business Name
3176
Shanghai Haoyuan Biotechnology Co., Ltd
TBG INC.

General Information
Number of Employees: 67 (As of 12/31/2012)
Outstanding Shares: 139,306,755 (As of 9/30/2024)
Shareholders: 39,234
Stock Exchange: TPO
Fax Number: +886 227856120


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024